Increased dendritic cell number and function following continuous in vivo infusion of granulocyte macrophage-colony-stimulating factor and interleukin-4

Blood

Volumn 99, Issue 8, 2002, Pages 2869-2879

  Basak, Saroj K ^a,b   Harui, Airi ^a,b   Stolina, Marina ^a,b   Sharma, Sherven ^a,b   Mitani, Kohnosuke ^a,b   Dubinett, Steven M ^a,b   Roth, Michael D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CD11 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL FUNCTION; CONTROLLED STUDY; DENDRITIC CELL; ENDOCYTOSIS; MALE; MOUSE; NONHUMAN; OSMOTIC PUMP; PHENOTYPE; PINOCYTOSIS; PRIORITY JOURNAL; SPLEEN CELL;

EID: 0037089317     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.8.2869     Document Type: Article

References (50)

1. The dendritic cell system and its role in immunogenicity
2. Immunobiology of dendritic cells
3. The influence of interleukin (IL)-4, IL-13, and Flt3 ligand on human dendritic cell differentiation from cord blood CD34+ progenitor cells
4. Generation of dendritic cells in vitro from peripheral blood mononuclear cells with granulocyte-macrophage-colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha for use in cancer immunotherapy
5. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: Multiple dendritic cell subpopulations identified
6. Developmental pathways of dendritic cells in vivo: Distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice
7. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and down-regulated by tumor necrosis factor alpha
8. Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage
9. Generation of functional human dendritic cells from adherent peripheral blood monocytes by CD40 ligation in the absence of granulocyte-macrophage colony-stimulating factor
10. A guide to the isolation and propagation of dendritic cells
11. Proliferating dendritic cell progenitors in human blood
12. Human CD14+ leukocytes acquire the phenotype and function of antigen-presenting dendritic cells when cultured in GM-CSF and IL-4
13. Granulocyte macrophage colony-stimulating factor and interleukin 4 enhance the number and antigen-presenting activity of circulating CD14+ and CD83+ cells in cancer patients
14. Phase I trial of recombinant granulocyte-macrophage colony-stimulating factor in patients with lung cancer: Clinical and immunologic effects
15. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in patients with refractory metastatic carcinoma
16. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor
17. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow
18. Generation of DC from mouse spleen cell cultures in response to GM-CSF: Immunophenotypic and functional analyses
19. GM-CSF-induced in vivo expansion of splenic dendritic cells and their strong costimulation activity
20. Polyethylene glycol-modified GM-CSF expands CD11b(high)CD11c(high) but no CD11b(low)-CD11c(high) murine dendritic cells in vivo: A comparative analysis with Flt3 ligand
21. Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo
22. Antitumor effect of murine colon carcinoma cells retrovirally transduced with interleukin-4 and granulocyte macrophage-colony stimulating factor genes
23. Induction of T cell dependent acquired immunity in syngeneic mice by the combined expression of interleukin-4 and granulocyte macrophage-colony stimulating factor gene in murine colon carcinoma cells
24. A comparison of gene transfer methods in human dendritic cells
25. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo
26. Functional comparison of spleen dendritic cells and dendritic cells cultured in vitro from bone marrow precursors
27. Bone marrow-derived dendritic cells serve as potent adjuvants for peptide-based antitumor vaccines
28. Inhibition of GM-CSF production by recombinant human interleukin-4: Negative regulator of hematopoiesis
29. Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells
30. Expression of surface antigens during the differentiation of human dendritic cells vs macrophages from blood monocytes in vitro
31. A phase I study of recombinant human interleukin-4 administered by the intravenous and subcutaneous route in patients with advanced cancer: Immunological studies
32. Soluble cytokine receptors as carrier proteins: Effects of soluble interleukin-4 receptors on the pharmacokinetics of murine interleukin-4
33. Constant subcutaneous infusion of rhlL-11 in mice: Efficient delivery enhances biological activity
34. Recovery from severe hematopoietic suppression using recombinant human granulocyte-macrophage colony-stimulating factor
35. Dendritic cell subtypes in mouse lymphoid organs: Cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes
36. IL-4 and CD40 ligation affect differently the differentiation, maturation, and function of human CD34+ cell-derived CD1a+CD14- and CD1a-CD14+ dendritic cell precursors in vitro
37. Effects of B cell stimulatory factor-1/interleukin 4 on hematopoietic progenitor cells
38. Actions of human interleukin-4/B-cell stimulatory factor-1 on proliferation and differentiation of enriched hematopoietic progenitor cells in culture
39. Effects of interleukin-4 on granulocyte-macrophage colony formation from murine bone marrow cells and hematopoietic reconstitution following murine allogeneic bone marrow transplantation
40. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas
41. Dendritic cells in the T-cell areas of lymphoid organs
42. Interleukin-12 and Flt3 Ligand differentially promote dendropoiesis in vivo
43. Differentiation of myeloid dendritic cells into CD8α-positive dendritic cells in vivo
44. Thymic dendritic cell precursors: Relationship to the T lymphocyte lineage and phenotype of the dendritic cell progeny
45. Thymic dendritic cells and T cells develop simultaneously in the thymus from a common precursor population
46. Mouse thymus dendritic cells: Kinetics of development and changes in surface markers during maturation
47. Development of CD8α-positive dendritic cells from a common myeloid progenitor
48. Role of CD8α+ and CD8α-dendritic cells in the induction of primary immune responses in vivo
49. Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand
50. Activated dendritic cells from bone marrow cells of mice receiving cytokine-expressing tumor cells are associated with the enhanced survival of mice bearing syngeneic tumors